According to our latest research, the global market size for Critical Care Antiarrhythmic Drugs reached USD 1.89 billion in 2024, with a robust compound annual growth rate (CAGR) of 5.2% projected from 2025 to 2033. By the end of 2033, the market is forecasted to attain a value of approximately USD 2.97 billion. This market growth is primarily driven by the increasing prevalence of cardiac arrhythmias, heightened awareness about the importance of timely intervention in critical care settings, and continuous advancements in drug formulations and delivery mechanisms.
growthmarketreports.com/repo...